CopyMark Law Group
4.9/5
Drawing for PEDIDERM

USPTO serial 97282042

PEDIDERM

Reviewed by CopyMark Law Group

Reg. 8128387Status 700Registered
Filing date
Status date
Registration date
Feb 3, 2026
Examiner
MCCARTHY,JOSEPH PATRICK
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PEDIDERM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Goods and services

ClassDescriptionStatusFirst use
044Dermatology services; Telemedicine servicesACTIVESep 10, 2025

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 3, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 3, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 9, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jan 9, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 6, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 6, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 6, 2026EX5GSOU EXTENSION 5 GRANTED—
Dec 21, 2025IUAFUSE AMENDMENT FILED—
Dec 21, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 21, 2025TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Dec 21, 2025NREVNOTICE OF REVIVAL - E-MAILED—
Dec 21, 2025PETGPETITION TO REVIVE-GRANTED—
Dec 21, 2025PROATEAS PETITION TO REVIVE RECEIVED—
Oct 21, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 20, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 14, 2025EXT5SOU EXTENSION 5 FILED—
Jun 4, 2025EX4GSOU EXTENSION 4 GRANTED—
May 22, 2025TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
May 22, 2025NREVNOTICE OF REVIVAL - E-MAILED—
May 22, 2025PETGPETITION TO REVIVE-GRANTED—
May 22, 2025PROATEAS PETITION TO REVIVE RECEIVED—
Apr 21, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 21, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 15, 2025EXT4SOU EXTENSION 4 FILED—
Jan 13, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 13, 2025EX3GSOU EXTENSION 3 GRANTED—
Dec 30, 2024TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Dec 30, 2024NREVNOTICE OF REVIVAL - E-MAILED—
Dec 30, 2024PETGPETITION TO REVIVE-GRANTED—
Dec 30, 2024PROATEAS PETITION TO REVIVE RECEIVED—
Oct 21, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 21, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 16, 2024EXT3SOU EXTENSION 3 FILED—
Jun 13, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 31, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 30, 2024EX2GSOU EXTENSION 2 GRANTED—
May 29, 2024TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
May 29, 2024NREVNOTICE OF REVIVAL - E-MAILED—
May 29, 2024PETGPETITION TO REVIVE-GRANTED—
May 29, 2024PROATEAS PETITION TO REVIVE RECEIVED—
Apr 15, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 15, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 14, 2024EXT2SOU EXTENSION 2 FILED—
Nov 30, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 29, 2023EX1GSOU EXTENSION 1 GRANTED—
Nov 24, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 11, 2023NREVNOTICE OF REVIVAL - E-MAILED—
Nov 9, 2023TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Nov 9, 2023NREVNOTICE OF REVIVAL - E-MAILED—
Nov 9, 2023PETGPETITION TO REVIVE-GRANTED—
Nov 9, 2023PROATEAS PETITION TO REVIVE RECEIVED—
Oct 16, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 16, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 14, 2023EXT1SOU EXTENSION 1 FILED—
Mar 14, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 17, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 17, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 28, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 13, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 8, 2022DOCKASSIGNED TO EXAMINER—
Mar 1, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 28, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance